Dolby Laboratories (DLB) is Reiterated by Dougherty & Company to Buy, Raises Price Target to $ 54

Dolby Laboratories (DLB) was Reiterated by Dougherty & Company to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 54 from a previous price target of $46 . Dougherty & Company advised their investors in a research report released on Apr 28, 2016.

Many Wall Street Analysts have commented on Dolby Laboratories. Company shares were Reiterated by Dougherty & Company on Apr 25, 2016 to “Buy”, Firm has raised the Price Target to $ 46 from a previous price target of $38 .Dolby Laboratories was Downgraded by JP Morgan to ” Neutral” on Apr 8, 2016. Company shares were Reiterated by Dougherty & Company on Mar 28, 2016 to “Buy”, Firm has raised the Price Target to $ 46 from a previous price target of $38 .

On the company’s financial health, Dolby Laboratories reported $0.82 EPS for the quarter, beating the analyst consensus estimate by $ 0.21 according to the earnings call on Apr 27, 2016. Analyst had a consensus of $0.61. The company had revenue of $274.30 million for the quarter, compared to analysts expectations of $263.96 million. The company’s revenue was up .9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.72 EPS.

Dolby Laboratories closed down -0.18 points or -0.42% at $42.48 with 2,06,521 shares getting traded on Wednesday. Post opening the session at $42.56, the shares hit an intraday low of $42.168 and an intraday high of $42.64 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

In a different news, on Feb 4, 2016, N William Jr Jasper (director) sold 7,759 shares at $35.49 per share price. According to the SEC, on Feb 4, 2016, Nicholas Jr Donatiello (director) sold 3,880 shares at $35.50 per share price. On Feb 3, 2016, Kevin J Yeaman (President and CEO) sold 2,504 shares at $35.62 per share price, according to the Form-4 filing with the securities and exchange commission.

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Dolby Laboratories

Leave a Reply

Dolby Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dolby Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.